Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?

about

Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?

Item

http://www.wikidata.org/entity/Q52595142

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Combination of basal insulin a ...... treatment of type 2 diabetes?

@en

Combination of basal insulin a ...... treatment of type 2 diabetes?

@nl

type

Item

label

Combination of basal insulin a ...... treatment of type 2 diabetes?

@en

Combination of basal insulin a ...... treatment of type 2 diabetes?

@nl

prefLabel

Combination of basal insulin a ...... treatment of type 2 diabetes?

@en

Combination of basal insulin a ...... treatment of type 2 diabetes?

@nl

P1476

Combination of basal insulin a ...... treatment of type 2 diabetes?

@en

P2093

Raquel C Lopes Assis Coelho

http://www.w3.org/2001/XMLSchema#string

Roberta Cobas

http://www.w3.org/2001/XMLSchema#string

Rodrigo Oliveira Moreira

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term safety and efficacy of insulin degludec in the management of type 2 diabetes

A systematic review of the associations between dose regimens and medication compliance.

Interventions for helping patients to follow prescriptions for medications.

Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy.

One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial

IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test.

Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people

Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes.

P2888

s13098-018-0327-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13098-018-0327-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103148499

http://www.w3.org/2001/XMLSchema#string

P698

29636825

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5883417

http://www.w3.org/2001/XMLSchema#string